$CNVS

Cineverse Reports First Quarter Fiscal Year 2027 Results

Cineverse (NASDAQ: CNVS) reported Q1 FY2027 revenue of $30.6M, up 175% year over year, with more than 60% from technology. Adjusted EBITDA was $0.5M. Cash from operations rose $13M. The company reaffirmed FY2027 guidance of $115M to $120M revenue and $10M to $20M adjusted EBITDA, and said 4.5B minutes streamed in the quarter.

Original reporting
Published Aug 13, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cineverse Reports First Quarter Fiscal Year 2027 Results — source image
Decision brief

The 30-second read

$CNVSNeutralMed
01

Why it matters

Q1 FY2027 shows rapid top-line growth and early automation time savings, alongside margin compression and continued losses. The reaffirmed FY2027 revenue and adjusted EBITDA range provides a concrete forward anchor for traders assessing execution credibility.

02

Market read

Traders can update models for CNVS using the quarter’s revenue/EBITDA/net loss, the stated cost-savings progress, and the reaffirmed FY2027 guidance range.

03

What to watch

Working capital is deeply negative and cash is low ($4.3M), so execution risk on cost synergies and customer retention could dominate the stock reaction even with guidance reaffirmed.

Relevance 8/10Novelty 8/10Timing: after-hours earnings release, guidance reaffirmation for FY2027

Background

Cineverse is transitioning from post-merger integration of Giant Worldwide and IndiCue toward synergy capture, with Matchpoint as the automation platform.

Company-level read

Ticker impact

$CNVSNeutralMedium confidence
Context

Cineverse reported Q1 FY2027 revenue of $30.6M, reaffirmed FY2027 guidance to $115-$120M revenue and $10-$20M adjusted EBITDA, and detailed post-acquisition integration progress.

Expected impact

Near-term trading likely hinges on whether investors view the guidance range and early synergy execution as credible versus the cash/working-capital strain.

Evidence & confidence

The article provides fresh quarterly datapoints (revenue, adjusted EBITDA, net loss) plus explicit FY2027 guidance and cost-savings progress, which are direct inputs to valuation and risk for CNVS.

Market effects

Highlights ongoing shift toward ad-tech and automation-driven media services, which can influence sentiment around streaming infrastructure and ad-tech monetization models.

Limited direct regional read-through; primarily company-specific execution in streaming/CTV workflows.

Modest global relevance, as the disclosures are specific to Cineverse’s integration and streaming/advertising technology rollout.

Counterpoint

The revenue surge is attributed largely to acquisition-driven new streams, while margins and net loss remain pressured, so organic durability may be less strong than headline growth implies.

Key entities

  • Cineverse Corp.

    NASDAQ-listed streaming technology and entertainment company reporting Q1 FY2027 results and reaffirming FY2027 guidance.

  • Matchpoint

    Automation platform Cineverse is using to migrate workflows and expand Media Services gross margins.

  • Sean McCabe

    Appointed Chief Financial Officer to strengthen finance organization for the post-acquisition business.

Related articles

$CNVSMed

Cineverse (CNVS) Q1 2027 Earnings Call Transcript

Cineverse (CNVS) reported Q1 2027 revenue of $30.6M, up 175%, driven by advertising tech and media services. Adjusted EBITDA was $500K, up $2.6M YoY. Net loss widened to $5.8M. Streaming engagement grew 33% to 4.5B minutes. FY2027 revenue guidance reaffirmed at $115M-$120M. Management noted seasonal ad softness in Q2 but expects recovery in H2.

$CNVSMed

Cineverse Corp. (CNVS): Results of Operations and Financial Condition

Cineverse Corp. (CNVS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cineverse Reports First Quarter Fiscal Year 2027 Results • First Quarter Revenue of $30.6 Million, a $19.5 Million or 175% Increase Over the Prior Year Quarter • More Than 60% of Total Revenues Were Technology Related • Adjusted EBITDA of $0.5 Million, a $2.6 Million

$CNVSMed

Cineverse Launches VAUDIO™ to Help Brands Expand Audio Campaigns to CTV

Cineverse (Nasdaq: CNVS) launched VAUDIO™, an ad-tech offering that converts existing audio ads (podcast, radio, or streaming audio) into CTV visuals and deploys them across connected TV inventory without a traditional video shoot. The company expects VAUDIO™ to contribute up to $12 million in annual revenue at a 15% to 20% margin, targeting the run rate by fiscal year end. Launch partners include A24 and others.

$CNVSMed

Cineverse (CNVS) Q4 2026 Earnings Call Transcript

Cineverse (CNVS) reported Q4 2026 revenue of $26.0 million (+67% y/y), driven by acquisitions including Giant Worldwide and IndiCue. Net income rose to $1.1 million (+51%). FY2026 revenue fell to $65.7 million (-16%) versus a prior-year comparison boosted by Terrifier 3. SVOD subscribers were 1.52 million (+13%). Management guided FY2027 revenue to $115–$120 million and adjusted EBITDA to $10–$20 million.

$CNVSMed

Cineverse Corp. (CNVS): Results of Operations and Financial Condition

Cineverse Corp. (CNVS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cnvs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Cineverse Reports Fourth Quarter and Fiscal Year 2026 Results • Transformative acquisitions of IndiCue and Giant Worldwide complete Cineverse’s evolution into an AI-driven, fully integrated entertainment technology company an

$NXHighAI 8/10

Why Quanex Stock Skyrocketed by 22% on Friday

Quanex Building Products (NX) reported Q3 net sales of $501.8M, up 1% YoY, and adjusted net income of $36M, up 14% YoY. Earnings per share beat estimates, driving a 22% stock price increase on Friday. The company attributed growth to favorable pricing and lower costs, despite tariff reimbursements and economic challenges.